DK3294756T3 - Retroviral partikel, omfattende mindst to forskellige indkapslede, ikke-virale RNA'er - Google Patents

Retroviral partikel, omfattende mindst to forskellige indkapslede, ikke-virale RNA'er Download PDF

Info

Publication number
DK3294756T3
DK3294756T3 DK16729025.3T DK16729025T DK3294756T3 DK 3294756 T3 DK3294756 T3 DK 3294756T3 DK 16729025 T DK16729025 T DK 16729025T DK 3294756 T3 DK3294756 T3 DK 3294756T3
Authority
DK
Denmark
Prior art keywords
retroviral particle
viral rnas
different encapsulated
encapsulated
different
Prior art date
Application number
DK16729025.3T
Other languages
English (en)
Inventor
Jean-Christophe Pages
Régis Gayon
Pascale Bouille
Original Assignee
Flash Therapeutics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR1554381A external-priority patent/FR3036118B1/fr
Application filed by Flash Therapeutics filed Critical Flash Therapeutics
Application granted granted Critical
Publication of DK3294756T3 publication Critical patent/DK3294756T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/02—Recovery or purification
    • C12N7/025—Packaging cell lines, e.g. transcomplementing cell lines, for production of virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04—Inactivation or attenuation; Producing viral sub-units
    • C12N7/045—Pseudoviral particles; Non infectious pseudovirions, e.g. genetically engineered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/85—Fusion polypeptide containing an RNA binding domain
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/16042—Use of virus, viral particle or viral elements as a vector virus or viral particle as vehicle, e.g. encapsulating small organic molecule
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16051—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16051—Methods of production or purification of viral material
    • C12N2740/16052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16071—Demonstrated in vivo effect
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/18011—Details ssRNA Bacteriophages positive-sense
    • C12N2795/18111—Leviviridae
    • C12N2795/18151—Methods of production or purification of viral material
    • C12N2795/18152—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
DK16729025.3T 2015-05-15 2016-05-13 Retroviral partikel, omfattende mindst to forskellige indkapslede, ikke-virale RNA'er DK3294756T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1554381A FR3036118B1 (fr) 2015-05-15 2015-05-15 Particule retrovirale comportant au moins deux arn non viraux encapsides.
FR1653280 2016-04-13
PCT/FR2016/051152 WO2016185125A1 (fr) 2015-05-15 2016-05-13 Particule rétrovirale comportant au moins deux arn non viraux encapsidés

Publications (1)

Publication Number Publication Date
DK3294756T3 true DK3294756T3 (da) 2021-02-22

Family

ID=56121117

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16729025.3T DK3294756T3 (da) 2015-05-15 2016-05-13 Retroviral partikel, omfattende mindst to forskellige indkapslede, ikke-virale RNA'er

Country Status (12)

Country Link
US (2) US11124775B2 (da)
EP (1) EP3294756B1 (da)
JP (1) JP6895391B2 (da)
CN (1) CN107624131B (da)
CA (1) CA2986051C (da)
DK (1) DK3294756T3 (da)
ES (1) ES2856901T3 (da)
HK (1) HK1244818A1 (da)
IL (1) IL255566B (da)
PT (1) PT3294756T (da)
SG (1) SG11201709336SA (da)
WO (1) WO2016185125A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3294756T (pt) * 2015-05-15 2021-03-04 Flash Therapeutics Partícula retroviral que contém pelo menos dois arns não virais encapsidados diferentes
FR3064276B1 (fr) * 2017-03-21 2021-03-19 Centre Nat Rech Scient Production d'arn par des levures a particules peseudo-virales recombinantes
CN108504689B (zh) * 2018-05-29 2021-01-29 上海本导基因技术有限公司 慢病毒载体及其递送外源rna的方法
AU2019343045A1 (en) * 2018-09-18 2021-05-13 Vnv Newco Inc. ARC-based capsids and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2375880A1 (en) * 1999-06-22 2000-12-28 Dnavec Research Inc. A vector for the expression of two foreign genes
WO2007038757A2 (en) 2005-09-28 2007-04-05 Attagene Inc. Methods and compositions for non-invasive assessment of gene expression
GB0526210D0 (en) * 2005-12-22 2006-02-01 Oxford Biomedica Ltd Vectors
JP6212039B2 (ja) * 2011-07-27 2017-10-11 ブクタリ 真核細胞の形質導入に有用なウイルスベースのベクター組成物
EP2831225A1 (en) * 2012-03-26 2015-02-04 The United States of America, As Represented by the Secretary, Dept. of Health & Human Services Office of Technology Transfer Delivery of packaged rna to mammalian cells
PT3294756T (pt) * 2015-05-15 2021-03-04 Flash Therapeutics Partícula retroviral que contém pelo menos dois arns não virais encapsidados diferentes
BR112018010639A2 (pt) * 2015-11-24 2019-01-22 Glaxosmithkline Ip Dev Ltd método de transfecção transitória para produção retroviral.
DK3455239T3 (da) * 2016-05-13 2021-07-05 Flash Therapeutics Partikel til indkapsling af et genomteknisk system
AU2017263138B2 (en) * 2016-05-13 2022-08-25 Flash Therapeutics Viral particle for RNA transfer, especially into cells involved in immune response

Also Published As

Publication number Publication date
CA2986051C (fr) 2023-09-26
EP3294756B1 (fr) 2020-12-02
WO2016185125A1 (fr) 2016-11-24
IL255566A (en) 2018-01-31
CN107624131B (zh) 2022-05-17
CN107624131A (zh) 2018-01-23
US20180135025A1 (en) 2018-05-17
ES2856901T3 (es) 2021-09-28
IL255566B (en) 2022-04-01
EP3294756A1 (fr) 2018-03-21
US20210301265A1 (en) 2021-09-30
CA2986051A1 (fr) 2016-11-24
SG11201709336SA (en) 2017-12-28
JP6895391B2 (ja) 2021-06-30
PT3294756T (pt) 2021-03-04
JP2018516558A (ja) 2018-06-28
HK1244818A1 (zh) 2018-08-17
US11124775B2 (en) 2021-09-21

Similar Documents

Publication Publication Date Title
HK1253065A1 (zh) 靶向蛋白質的化合物、其組合物、方法和用途
DK3433368T3 (da) Transreplikerende rna
IL251145A0 (en) Galnac phosphoramidites, their conjugates with nucleic acid and their use
EP3313989A4 (en) Modified crispr rna and modified single crispr rna and uses thereof
SG11201707663SA (en) Lyophilization of rna
BR112017023853A2 (pt) composições de nanopartícula para terapia sustentada.
ES2968011T3 (es) Nuevas formulaciones de cannabinoides
IL263437B (en) 5'-cyclophosphonate modified nucleotides, preparations containing them and their uses
DK3297637T3 (da) Benzen-1,3,5-tricarboxamidderivater og anvendelser deraf
FR3036037B1 (fr) Harnais d'encordement perfectionne
DK3317415T3 (da) UTR'er, som forøger translationseffektiviteten for RNA-molekyler
DK3351633T3 (da) Antisense-nukleinsyre
DK3319597T3 (da) Sammensætninger, der omfatter antistof-duocarmycin-lægemiddelkonjugater
HK1256752A1 (zh) 取代的苯並咪唑，它們的製備和它們作為藥物的用途
DK3294756T3 (da) Retroviral partikel, omfattende mindst to forskellige indkapslede, ikke-virale RNA'er
IL237852A0 (en) Antibodies against amphigoline, medical preparations containing them and their use
HK1249898A1 (zh) 一種c，o-螺環芳基糖苷類化合物及其製備和應用
BR112015028765A2 (pt) derivados de nucleosídeo substituído 4'-azido, 3'-desoxi-3'-fluoro
FR3034130B1 (fr) Demontage d'aubes de soufflante
FR3026399B1 (fr) Grue, notamment grue-derrick
FR3030523B1 (fr) Nouveaux composes de la famille des n-acylamino-amides,compositions les comprenant, et utilisations
FR3018277B1 (fr) Composition fumigene incapacitante comprenant de la resine d'oleum capsicum microencapsulee
IL254578A0 (en) Abscisic acid (s)-2' vinyl derivatives
FR3031486B1 (fr) Balai d'essuie-glace
ES1138820Y (es) Juego de construccion perfeccionado